rtCGM Proven to Enhance Diabetes Engagement and Confidence for People Living with T2D
A recent clinical study1 demonstrated that real-time continuous glucose monitoring (rtCGM) systems, like Dexcom G7, can offer substantial benefits to people living with type 2 diabetes (T2D) who are on non-intensive insulin therapy.
Researchers examined the effectiveness of Dexcom rtCGM in individuals living with T2D using basal insulin or other non-intensive insulin regimens. Participants wore an rtCGM system for three months and were questioned on their level of perceived control of their diabetes management before the study and at the conclusion.
The results showed that using Dexcom CGM can offer psychological benefits, enhancing the users’ sense of control over their diabetes management.
Dexcom rtCGM Enhances Perceived Control, Boosts Confidence and Motivation
Researchers found that >90% of study participants reported higher levels of perceived control*,1 of diabetes management after using the Dexcom rtCGM System for the designated period.
Notably, perceived control is linked to increased confidence and motivation, highlighting the positive impact real-time continuous glucose monitoring can have on individuals living with T2D.
Using rtCGM can foster a greater level of comfort with, and empowerment over, an individual’s diabetes care. These clinical outcomes demonstrated that rtCGM can be a powerful tool in improving diabetes self-management, even for those not receiving additional behavioural coaching or guidance.
Study Demonstrates More Emotional Benefits with rtCGM
Diabetes management can be a daily challenge for people living with the condition and can have an impact on their mental and emotional health. The real-time glucose data available to users of rtCGM devices can help them improve and manage their own care and assist in decreasing the stress of living with diabetes.
The study revealed a 36% reduction in the emotional burden of living with T2D† at follow up, with many study participants self-reporting a decreased emotional impact of diabetes.
Confidently Prescribe Dexcom CGM for Individuals Living with T2D
The study demonstrated that using a real-time continuous glucose monitoring system, like Dexcom G7, can empower individuals living with T2D on non-intensive insulin therapy, reducing emotional stress, improving perceived control, and fostering greater confidence in diabetes self-management.
* Self-reported based on the BIPQ (Brief Illness Perception Questionnaire) 0-80 scale (p<0.05).
† Low to High group (n=9) self-reported based on the BIPQ (Brief Illness Perception Questionnaire) 0-80 scale (p<0.05).
1 Crawford MA, et al. Diabetes. 2023;72(Suppl 1):677-P.
MAT-7650 V1.0